Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors

NCT06076135 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Malignant Solid Neoplasm
Radiotherapy
Immune Checkpoint Blockade
Resistance to Immunotherapy

Interventions

RADIATION: Intestinal Low Dose Radiotherapy-1Gy
RADIATION: Intestinal Low Dose Radiotherapy-2-3Gy
DRUG: PD-1/PD-L1 Inhibitors

Sponsor

Chuangzhen Chen